The Federal Circuit ruled in favor of Medtronic (NYSE:MDT) subsidiary Cardiocom yesterday, upholding an earlier ruling in a continuing spat between Robert Bosch Healthcare and the Fridley, Minn.-based medical giant. The U.S. Court of Appeals for the Federal Circuit ruled that a U.S. Patent Trial and Appeal’s Board earlier decision not to review 2 patents from Robert […]
Cardiocom
Appeals court upholds patent win for Medtronic’s Cardiocom
A federal appeals court yesterday upheld a win for Medtronic (NYSE:MDT) subsidiary Cardiocom in a patent battle with Robert Bosch Healthcare Systems. The U.S. Court of Appeals for the Federal Circuit upheld rulings by the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board that invalidated a trio of Bosch patents. Bosch had alleged that the […]
Medtronic’s Cardiocom inks another home health care deal
UPDATE: Medtronic drops $200M on Cardiocom
Medtronic (NYSE:MDT) bought Cardiocom LLC for $200 million in cash in a bid to get into the disease management business.
Chanhassen, Minn.-based Cardiocom makes devices aimed at helping to manage chronic conditions like diabetes or heart disease. Fridley, Minn.-based Medtronic said the acquisition is its entree into the disease management sphere.